Back to Agenda
S9 - Practical Implementation of Next-Generation Post-Marketing Safety Studies
Session Chair(s)
Min-Jung Lim, MPHARM, RPH
CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of
Seongsik Kang, MD
Senior Vice President, HANDOK, Inc, Korea, Republic of
Speaker(s)
Fuminori Okubo
Director, Strategic Excellence Dept, RWD Solutions Div., CMIC Co., Ltd., Japan
Current Status of RWD-Based Safety Studies (Database Studies) in Japanese PMS
Hye Young Kim, MD, PHD
VP, Head of Medical Affairs, SK bioscience, Korea, Republic of
Case Study : RWD-Based Safety Study in RMP – Korea
Seong-jun Byun, PHD
Director, DreamCIS Inc., Korea, Republic of
Practical Implementation of Next-Generation Post-Marketing Safety Studies From RMP Safety Questions to Practical RWD Study Design in Korea
Seung Hee Jeong, PHD
RWE Generation Team Lead, , Pfizer Korea, Korea, Republic of
Jung Ae Kim, PHD
Professor, Pharmacogenomics Research Center, Inje University, Korea, Republic of
So Hee Kim, PHD
Director / Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
Have an account?